Proposal for use of a standard side effect scoring system in studies exploring Helicobacter pylori treatment regimens

European Journal of Gastroenterology and Hepatology

Volumn 8, Issue 7, 1996, Pages 641-643

  De Boer, Wink A ^a   Thys, Jacob C ^b   Borody, Thomas J ^c   Graham, David Y ^d   O'Morain, Colm ^e   Tytgat, Guido N J ^f  

^a ST ANNA HOSPITAL   (Netherlands)

^b Bethesda Hospital   (Netherlands)

^c Centre for Digestive Diseases   (Australia)

^d MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e ADELAIDE AND MEATH HOSPITAL   (Ireland)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Helicobacter pylori; Side effect profile

Indexed keywords

ANTIBIOTIC AGENT; BISMUTH; METRONIDAZOLE;

ARTICLE; BACTERIAL INFECTION; CLINICAL TRIAL; DATA ANALYSIS; DRUG TOLERABILITY; DRUG TOXICITY; HELICOBACTER PYLORI; HUMAN; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM; STANDARDIZATION; TASTE DISORDER; TREATMENT PLANNING;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTI-BACTERIAL AGENTS; DRUG THERAPY, COMBINATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS;

EID: 0029900373     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. de Boer WA, Tytgat GNJ: The best therapy for Helicobacter pylori infection: should efficacy or side effect profile determine our choice? Scand J Gastroenterol 1995, 30:401-407.
2. Marshall BJ: Helicobacter pylori. Quadrennial review. Am J Gastroenterol 1994, 89:S116-S128.
3. de Boer WA, Tytgat GNJ: 90% cure: which anti-Helicobacter therapy can achieve this treatment goal? [editorial] Am J Gastroenterol 1995, 90:1381-1382.
4. Bayerdorffer E, Mannes GA, Sommer A, Hochter W, Weingart J, Hatz R, et al.: High dose omeprazole treatment combined with amoxicillin eradicates H. pylori. Eur J Gastroenterol Hepatol 1992, 4:697-702.
5. Atherton JC, Cullen DJE, Hawkey CJ, Spiller RC: Enhanced eradication of H. pylori by pre versus post prandial amoxicillin suspension with omeprazole [abstract]. Gastroenterology 1994, 106:A114.
6. Xia H, Daw MA, Sant S Beattie S, Keane CT, O'Morain CA: Clinical efficacy of triple therapy in H. pylori associated duodenal ulcer. Eur J Gastroenterol Hepatol 1993, 5:141-144.
7. Thys JC, van Zwet AA, Moolenaar W, Wolfhagen MJHM, ten Bokkel Huining J: Triple therapy versus amoxicillin plus omeprazole for the treatment of Helicobacter pylori infection. Am J Gastroenterol 1996, 91:93-97.
8. Penston JG: Helicobacter pylori eradication - understandable caution - but no excuse for inertia. Aliment Pharmacol Ther 1994, 8:369-389.
9. de Boer WA, Driessen WMM, Jansz AR, Tytgat GNJ: Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet 1995, 345:817-820.
10. Tefera S, Berstad A, Bang CJ, et al.: Bismuth based triple therapy of Helicobacter pylori associated peptic ulcer disease. Metronidazole is critical for eradication. Ranitidine decreases abdominal pain during therapy [abstract FF29]. Scand J Gastroenterol 1995, 30(suppl. 209):46.
11. Borody TJ, Andrews P, Fracchia G, Brandi S, Shortis NP, Bae H: Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori. Gut 1995, 37:477-481.
12. Lamb GC, Green SS, Heron J: Can physicians warn patients of potential side effects without fear of causing those side effects? Arch Intern Med 1994, 154:2753-2756.
13. Graham DY, Karttunen TJ, Genta RM: The evaluation of treatment of H. pylori infections: strategies for the design of clinical trials. Endoscopia Digestiva 1994, 6:991-1001.
14. Thys JC, van Zwet AA, Oey HB: Efficacy and side effects of a triple drug regimen for the eradication of Helicobacter pylori. Scand J Gastroenterol 1993, 28:934-938.
15. de Boer WA, Driessen WMM, Potters HVPJ, Tytgat GNJ: Randomized study comparing 1 with 2 weeks of quadruple therapy for eradicating Helicobacter pylori. Am J Gastroenterol 1994, 89:1993-1997.